Published in PLoS One on May 16, 2007
Interaction of the tick immune system with transmitted pathogens. Front Cell Infect Microbiol (2013) 1.32
Tick salivary compounds: their role in modulation of host defences and pathogen transmission. Front Cell Infect Microbiol (2013) 1.31
Impact of climate trends on tick-borne pathogen transmission. Front Physiol (2012) 1.21
Identification and characterization of Ixodes scapularis antigens that elicit tick immunity using yeast surface display. PLoS One (2011) 1.21
Antibodies against a tick protein, Salp15, protect mice from the Lyme disease agent. Cell Host Microbe (2009) 1.19
Inhibition of neutrophil function by two tick salivary proteins. Infect Immun (2009) 1.16
Tick histamine release factor is critical for Ixodes scapularis engorgement and transmission of the lyme disease agent. PLoS Pathog (2010) 1.12
Borrelia burgdorferi and tick proteins supporting pathogen persistence in the vector. Future Microbiol (2013) 1.12
Differential salivary gland transcript expression profile in Ixodes scapularis nymphs upon feeding or flavivirus infection. Ticks Tick Borne Dis (2012) 0.96
A systems level analysis reveals transcriptomic and proteomic complexity in Ixodes ricinus midgut and salivary glands during early attachment and feeding. Mol Cell Proteomics (2014) 0.96
Comparative microarray analysis of Rhipicephalus (Boophilus) microplus expression profiles of larvae pre-attachment and feeding adult female stages on Bos indicus and Bos taurus cattle. BMC Genomics (2010) 0.96
Molecular characterization of novel sulfotransferases from the tick, Ixodes scapularis. BMC Biochem (2011) 0.85
Autocrine/paracrine dopamine in the salivary glands of the blacklegged tick Ixodes scapularis. J Insect Physiol (2014) 0.84
Identification of 24h Ixodes scapularis immunogenic tick saliva proteins. Ticks Tick Borne Dis (2015) 0.81
Feeding by Amblyomma maculatum (Acari: Ixodidae) enhances Rickettsia parkeri (Rickettsiales: Rickettsiaceae) infection in the skin. J Med Entomol (2014) 0.81
Absence of sodA Increases the Levels of Oxidation of Key Metabolic Determinants of Borrelia burgdorferi. PLoS One (2015) 0.81
Vaccination against Lyme disease: past, present, and future. Front Cell Infect Microbiol (2013) 0.79
Application of M13 phage display for identifying immunogenic proteins from tick (Ixodes scapularis) saliva. BMC Biotechnol (2015) 0.79
Target validation of highly conserved Amblyomma americanum tick saliva serine protease inhibitor 19. Ticks Tick Borne Dis (2015) 0.76
Factorial microarray analysis of zebra mussel (Dreissena polymorpha: Dreissenidae, Bivalvia) adhesion. BMC Genomics (2010) 0.76
Host Immune Evasion by Lyme and Relapsing Fever Borreliae: Findings to Lead Future Studies for Borrelia miyamotoi. Front Immunol (2017) 0.75
Vaccination against Bm86 Homologues in Rabbits Does Not Impair Ixodes ricinus Feeding or Oviposition. PLoS One (2015) 0.75
Characterization of the early local immune response to Ixodes ricinus tick bites in human skin. Exp Dermatol (2016) 0.75
Distinctive amino acid composition profiles in salivary proteins of the tick Ixodes scapularis. Ticks Tick Borne Dis (2011) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics (2003) 82.89
Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci U S A (1990) 11.10
Quantitative analysis of mRNA amplification by in vitro transcription. Nucleic Acids Res (2001) 9.62
Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. Proc Natl Acad Sci U S A (2000) 7.67
Fundamentals of experimental design for cDNA microarrays. Nat Genet (2002) 7.49
Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc Natl Acad Sci U S A (1996) 5.34
The biological and social phenomenon of Lyme disease. Science (1993) 4.76
Duration of tick attachment and Borrelia burgdorferi transmission. J Clin Microbiol (1987) 4.01
Growth and migration of Borrelia burgdorferi in Ixodes ticks during blood feeding. Am J Trop Med Hyg (1995) 3.04
The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature (2005) 2.82
An annotated catalog of salivary gland transcripts from Ixodes scapularis ticks. Insect Biochem Mol Biol (2005) 2.80
Cutaneous basophil hypersensitivity. II. A light and electron microscopic description. J Exp Med (1970) 2.61
A new tick-borne encephalitis-like virus infecting New England deer ticks, Ixodes dammini. Emerg Infect Dis (1997) 2.09
Host immunity to ticks. Annu Rev Entomol (1996) 2.08
Exploring the sialome of the tick Ixodes scapularis. J Exp Biol (2002) 1.88
Salp15, an ixodes scapularis salivary protein, inhibits CD4(+) T cell activation. Immunity (2002) 1.75
Purification, cloning, and expression of a novel salivary anticomplement protein from the tick, Ixodes scapularis. J Biol Chem (2000) 1.73
Tick resistance: basophils in skin reactions of resistant guinea pigs. Int J Parasitol (1973) 1.72
Acquisition and transmission of the agent of human granulocytic ehrlichiosis by Ixodes scapularis ticks. J Clin Microbiol (1998) 1.64
Salp25D, an Ixodes scapularis antioxidant, is 1 of 14 immunodominant antigens in engorged tick salivary glands. J Infect Dis (2001) 1.45
An antivector vaccine protects against a lethal vector-borne pathogen. PLoS Pathog (2006) 1.44
The immunomodulatory factors of bloodfeeding arthropod saliva. Parasite Immunol (2000) 1.42
Borrelia burgdorferi and Babesia microti: efficiency of transmission from reservoirs to vector ticks (Ixodes dammini). Exp Parasitol (1990) 1.41
Infestation with pathogen-free nymphs of the tick Ixodes scapularis induces host resistance to transmission of Borrelia burgdorferi by ticks. Infect Immun (1997) 1.41
Prevention of Borrelia burgdorferi transmission in guinea pigs by tick immunity. Am J Trop Med Hyg (1998) 1.40
Acquired resistance to ticks. I. Passive transfer of resistance. Immunology (1976) 1.37
Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis. Infect Immun (2001) 1.26
The Ixodes scapularis Genome Project: an opportunity for advancing tick research. Trends Parasitol (2005) 1.26
The tick protective antigen, 4D8, is a conserved protein involved in modulation of tick blood ingestion and reproduction. Vaccine (2006) 1.24
Tick-host interactions: saliva-activated transmission. Parasitology (2004) 1.24
Exposed and concealed antigens as vaccine targets for controlling ticks and tick-borne diseases. Parasite Immunol (2006) 1.21
Identification of an IL-2 binding protein in the saliva of the Lyme disease vector tick, Ixodes scapularis. J Immunol (2001) 1.21
A novel family of anticoagulants from the saliva of Ixodes scapularis. Insect Mol Biol (2002) 1.21
Clethrionomys glareolus, but not Apodemus flavicollis, acquires resistance to Ixodes ricinus L., the main European vector of Borrelia burgdorferi. Parasite Immunol (1995) 1.20
Penthalaris, a novel recombinant five-Kunitz tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick vector of Lyme disease, Ixodes scapularis. Thromb Haemost (2004) 1.20
Resistance to tick-borne Francisella tularensis by tick-sensitized rabbits: allergic klendusity. Am J Trop Med Hyg (1979) 1.19
Hypersensitivity to ticks and Lyme disease risk. Emerg Infect Dis (2005) 1.19
Recruitment of macrophages and polymorphonuclear leukocytes in Lyme carditis. Infect Immun (2006) 1.12
Ixodes ricinus L.: mast cells, basophils and eosinophils in the sequence of cellular events in the skin of infested or re-infested rabbits. Parasitology (1982) 1.12
Passive transfer of resistance in rabbits infested with adult Ixodes ricinus L: humoral factors influence feeding and egg laying. Experientia (1979) 1.11
Immunity to ticks. Adv Parasitol (1980) 1.09
Characterization of three Ixodes scapularis cDNAs protective against tick infestations. Vaccine (2005) 1.07
Immunology of the tick-host interaction and the control of ticks and tick-borne diseases. Parasitol Today (1999) 1.05
Ixodes scapularis: salivary kininase activity is a metallo dipeptidyl carboxypeptidase. Exp Parasitol (1998) 1.05
Characterization of the B-cell inhibitory protein factor in Ixodes ricinus tick saliva: a potential role in enhanced Borrelia burgdoferi transmission. Immunology (2004) 0.99
A cross-reactive tick cement antigen is a candidate broad-spectrum tick vaccine. Vaccine (2005) 0.97
Immunological control of hematophagous arthropod vectors: utilization of novel antigens. Vet Parasitol (1988) 0.92
Tick antigens recognized by serum from a guinea pig resistant to infestation with the tick Rhipicephalus appendiculatus. J Parasitol (1986) 0.87
Immunology of interactions between ticks and laboratory animals. Exp Appl Acarol (1989) 0.87
RNA interference: applicability in tick research. Exp Appl Acarol (2002) 0.87
Molecular individuality and adaptation of the tick Rhipicephalus appendiculatus in changed feeding environments. Med Vet Entomol (2001) 0.86
Issues in tick vaccine development: identification and characterization of potential candidate vaccine antigens. Microbes Infect (2000) 0.86
Application of amplified RNA and evaluation of cRNA targets for spotted-oligonucleotide microarray. Biochem Biophys Res Commun (2004) 0.84
Ixodid-host immune interaction. Identification and characterization of relevant antigens and tick-induced host immunosuppression. Vet Parasitol (1986) 0.84
Cutaneous basophil-associated resistance to ectoparasites (ticks). I. Transfer with immune serum or immune cells. Immunology (1982) 0.83
Salivary gland antigens of Ixodes dammini are glycoproteins that have interspecies cross-reactivity. J Parasitol (1991) 0.80
Successful interrupted feeding of adult Rhipicephalus appendiculatus (Ixodidae) is accompanied by reprogramming of salivary gland protein expression. Parasitology (1999) 0.80
Dot-ELISA assessment of guinea pig antibody responses to repeated Dermacentor andersoni infestations. J Parasitol (1986) 0.79
Acquired resistance of guinea pigs to Dermacentor andersoni mediated by humoral factors. J Parasitol (1993) 0.78
Isolation and characterization of salivary antigens from the female tick, Dermacentor andersoni. Parasite Immunol (1987) 0.77
Differential recognition of saliva antigens from the ixodid tick Amblyomma hebraeum (Acari: Ixodidae) by sera from infested and immunized rabbits. J Med Entomol (1993) 0.76
Global identification of human transcribed sequences with genome tiling arrays. Science (2004) 17.85
NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell (2011) 9.75
The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell (2009) 7.88
Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med (2004) 7.49
Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science (2006) 6.55
A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol (2009) 5.26
RNA interference screen for human genes associated with West Nile virus infection. Nature (2008) 4.93
Distribution of NF-kappaB-binding sites across human chromosome 22. Proc Natl Acad Sci U S A (2003) 3.89
Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet (2006) 3.57
STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc Natl Acad Sci U S A (2003) 3.46
The circadian clock controls toll-like receptor 9-mediated innate and adaptive immunity. Immunity (2012) 3.43
Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity (2011) 3.38
OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J Clin Invest (2004) 3.38
Systematic prediction and validation of breakpoints associated with copy-number variants in the human genome. Proc Natl Acad Sci U S A (2007) 3.35
Essential role for OspA/B in the life cycle of the Lyme disease spirochete. J Exp Med (2004) 3.02
Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA. Nat Mater (2009) 2.87
The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature (2005) 2.82
Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat Med (2002) 2.77
GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals. Science (2012) 2.69
Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing. Immunity (2009) 2.66
Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol (2010) 2.63
TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi. Cell (2004) 2.62
Host feeding patterns of Culex mosquitoes and West Nile virus transmission, northeastern United States. Emerg Infect Dis (2006) 2.58
Molecular adaptation of Borrelia burgdorferi in the murine host. J Exp Med (2002) 2.49
The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. Cell Rep (2012) 2.45
IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature (2012) 2.36
Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc Natl Acad Sci U S A (2010) 2.33
STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem (2002) 2.28
CREB binds to multiple loci on human chromosome 22. Mol Cell Biol (2004) 2.28
Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes. J Virol (2006) 2.20
Age-associated defect in human TLR-1/2 function. J Immunol (2007) 2.20
A tick antioxidant facilitates the Lyme disease agent's successful migration from the mammalian host to the arthropod vector. Cell Host Microbe (2007) 2.17
Epidemiology of West Nile virus in Connecticut: a five-year analysis of mosquito data 1999-2003. Vector Borne Zoonotic Dis (2004) 2.15
Rab 5 is required for the cellular entry of dengue and West Nile viruses. J Virol (2007) 2.12
Human Borrelia miyamotoi infection in the United States. N Engl J Med (2013) 2.11
Silent substitutions predictably alter translation elongation rates and protein folding efficiencies. J Mol Biol (2012) 2.04
IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection. J Immunol (2003) 2.03
Global changes in STAT target selection and transcription regulation upon interferon treatments. Genes Dev (2005) 2.01
Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol (2009) 2.00
Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J Virol (2008) 1.93
Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci U S A (2012) 1.91
Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J Virol (2006) 1.84
Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect Immun (2004) 1.82
Aging promotes neutrophil-induced mortality by augmenting IL-17 production during viral infection. Cell Host Microbe (2009) 1.78
West Nile virus: a growing concern? J Clin Invest (2004) 1.77
Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis (2002) 1.75
Salp15, an ixodes scapularis salivary protein, inhibits CD4(+) T cell activation. Immunity (2002) 1.75
A case of meningoencephalitis by the relapsing fever spirochaete Borrelia miyamotoi in Europe. Lancet (2013) 1.73
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. Vaccine (2009) 1.72
Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus. J Virol (2005) 1.72
PEGylated PLGA nanoparticles for the improved delivery of doxorubicin. Nanomedicine (2009) 1.70
Slowing bacterial translation speed enhances eukaryotic protein folding efficiency. J Mol Biol (2010) 1.70
ExpressYourself: A modular platform for processing and visualizing microarray data. Nucleic Acids Res (2003) 1.68
A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity. J Infect Dis (2007) 1.68
Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination. J Clin Microbiol (2003) 1.65
Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer. Proc Natl Acad Sci U S A (2013) 1.64
Detection of human anti-flavivirus antibodies with a west nile virus recombinant antigen microsphere immunoassay. J Clin Microbiol (2004) 1.59
Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. J Clin Invest (2007) 1.57
Disruption of Ixodes scapularis anticoagulation by using RNA interference. Proc Natl Acad Sci U S A (2004) 1.56
A supervised hidden markov model framework for efficiently segmenting tiling array data in transcriptional and chIP-chip experiments: systematically incorporating validated biological knowledge. Bioinformatics (2006) 1.54
Anaplasma phagocytophilum utilizes multiple host evasion mechanisms to thwart NADPH oxidase-mediated killing during neutrophil infection. Infect Immun (2004) 1.52
Repression of rac2 mRNA expression by Anaplasma phagocytophila is essential to the inhibition of superoxide production and bacterial proliferation. J Immunol (2002) 1.52
Borrelia burgdorferi lacking BBK32, a fibronectin-binding protein, retains full pathogenicity. Infect Immun (2006) 1.52
Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain. J Virol (2008) 1.49
Salivating for knowledge: potential pharmacological agents in tick saliva. PLoS Med (2008) 1.46
A tick mannose-binding lectin inhibitor interferes with the vertebrate complement cascade to enhance transmission of the lyme disease agent. Cell Host Microbe (2011) 1.44
The Lyme disease agent Borrelia burgdorferi requires BB0690, a Dps homologue, to persist within ticks. Mol Microbiol (2006) 1.44
Salp15 binding to DC-SIGN inhibits cytokine expression by impairing both nucleosome remodeling and mRNA stabilization. PLoS Pathog (2008) 1.43
Examination of the Borrelia burgdorferi transcriptome in Ixodes scapularis during feeding. J Bacteriol (2002) 1.43
Integrative microarray analysis of pathways dysregulated in metastatic prostate cancer. Cancer Res (2007) 1.41
Adaptation of Borrelia burgdorferi in the vector and vertebrate host. Microbes Infect (2003) 1.41
Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products predisposing to preterm labor. J Immunol (2010) 1.39
Age-associated elevation in TLR5 leads to increased inflammatory responses in the elderly. Aging Cell (2011) 1.39
Cutting edge: CD4 is the receptor for the tick saliva immunosuppressor, Salp15. J Immunol (2006) 1.39
West Nile Virus: biology, transmission, and human infection. Clin Microbiol Rev (2012) 1.38
A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus. Gastroenterology (2011) 1.38
Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus. J Infect Dis (2011) 1.38
A paradoxical role for neutrophils in the pathogenesis of West Nile virus. J Infect Dis (2010) 1.37
IL-10 signaling blockade controls murine West Nile virus infection. PLoS Pathog (2009) 1.35
Invasion and survival strategies of Anaplasma phagocytophilum. Cell Microbiol (2003) 1.35
Tick-host-pathogen interactions in Lyme borreliosis. Trends Parasitol (2007) 1.34
Absence of innate MyD88 signaling promotes inducible allograft acceptance. J Immunol (2006) 1.33
FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences. Mol Cell Biol (2006) 1.32